XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection

The unprecedented emergence and spread of SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic, underscores the need for diagnostic and therapeutic technologies that can be rapidly tailored to novel threats. Here, we show that site-specific RNA endonuclease XNAzymes – artificial catalys...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerber, Pehuén Pereyra, Donde, Maria J., Matheson, Nicholas J., Taylor, Alexander I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668987/
https://www.ncbi.nlm.nih.gov/pubmed/36385143
http://dx.doi.org/10.1038/s41467-022-34339-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668987/
https://www.ncbi.nlm.nih.gov/pubmed/36385143
http://dx.doi.org/10.1038/s41467-022-34339-w

Ejemplares similares